Peptide Initiative
Back to Larazotide

Clinical trials

Every registered trial of Larazotide

10 studies.

Plain-Language Summary

Plain-language reading of the public trial registries.

In short

  • Very little human research on Larazotide has been registered.
  • 10 registered studies in total.
  • None are currently enrolling — this research has already happened.

What kind of research

  • 10 studies actually gave the peptide to volunteers and measured what happened. This is the kind of study that can show whether something works.
  • About 1,211 people took part in those.

A registered trial is a plan, not a result. Registration means a study was declared in advance; it says nothing about whether the peptide worked, and a trial can be registered and then abandoned.

Filter

Showing 10 of 10 trials for Larazotide.

  • NCT05747534 Phase 2Completed107 enrolled2023

    AT1001 for the Treatment of Long COVID

    Massachusetts General Hospital

    Long COVID · Long COVID-19 · Post Acute COVID-19 Syndrome · Post Acute Sequelae of COVID-19

  • NCT05022303 Phase 2Terminated12 enrolled2021

    AT1001 for the Treatment of COVID-19 Related MIS-C

    Massachusetts General Hospital

    Covid19 · Multisystem Inflammatory Syndrome in Children

  • NCT03569007 Phase 3Terminated307 enrolled2019

    Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms

    9 Meters Biopharma, Inc.

    Celiac Disease

  • NCT01396213 Phase 2Completed342 enrolled2011

    A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease

    9 Meters Biopharma, Inc.

    Celiac Disease

  • NCT00889473 Phase 2Completed42 enrolled2009

    Study of the Efficacy of Larazotide Acetate to Treat Celiac Disease

    9 Meters Biopharma, Inc.

    Celiac Disease

  • NCT00620451 Phase 2Completed105 enrolled2008

    Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac Disease

    9 Meters Biopharma, Inc.

    Celiac Disease

  • NCT00492960 Phase 2Completed171 enrolled2007

    Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease

    9 Meters Biopharma, Inc.

    Celiac Disease

  • NCT00362856 Phase 2Completed80 enrolled2006

    Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects

    9 Meters Biopharma, Inc.

    Celiac Disease

  • NCT00386490 Phase 1Completed24 enrolled2006

    Safety of Larazotide Acetate in Healthy Volunteers

    9 Meters Biopharma, Inc.

    Healthy

  • NCT00386165 Phase 1Completed21 enrolled2005

    Safety Study of Larazotide Acetate to Treat Celiac Disease.

    9 Meters Biopharma, Inc.

    Celiac Disease

Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered in more than one registry is counted once. A study is listed when Larazotide is named as an intervention. A registered trial is a plan, not a result — registration says nothing about whether the peptide worked.